New drug ‘can kill leukaemia’
London, Nov 3 (ANI): Scientists from Trinity College Dublin (TCD) have discovered a new drug that can destroy cancerous cells in adult leukaemia patients who have developed resistance to other treatments.
Lead researcher Professor Mark Lawler, of TCD’s school of medicine, said the research was “at an early stage” and it could be another three to five years before the drug called PBOX-15 is used as a life saving treatment.
“Now we have to move it on to see if there are any side effects and bring it forward as a potential therapy for patients,” the Telegraph quoted Lawler as saying.
“But it’s very exciting.
“We want to give hope to cancer patients,” he added.
During the study, PBOX-15 was found to attack and break down the skeleton in leukaemia cells in samples given by patients.
It was also found to effectively treat Chronic Lymphocytic Leukaemia (CLL), a type of cancer of the blood and bone marrow, which is the most common leukaemia in the western world in adults.
The research team also involving researchers from University of Sienna, Italy have found PBOX- 15 was more effective than the current medication, fludarabine, used to treat the disease and also killed CLL cells that were resistant to treatment. (ANI)
Related Posts
Leukaemia vaccine set for human trials
London, Jan 4 (ANI): A vaccine for leukaemia is set to undergo human trials for the first time.
Researchers from University College London have developed a treatment that can be used to stop the disease returning after chemotherapy or bone... |
Two units of umbilical cord blood ‘reduce leukemia recurrence risk’
Washington, Nov 14 (ANI): If patients with acute leukaemia are transplanted with two units of umbilical cord blood (UCB), their risk of the disease recurrence is significantly reduced, according to a new study from the Masonic Cancer Center, University... |
Mums can ‘infect’ unborn child with cancer
London, Oct 13 (ANI): Solving a longstanding puzzle, British scientists have finally proved that cancer cells can pass on from the mother to her unborn child.
While there are very rare cases where a mother and child appear to share the same cancer, but... |
Cells critical to childhood leukemia identified
The cells that cause a common type of childhood leukaemia - T cell Acute Lymphoblastic Leukaemia (T-ALL) - have been identified by scientists at The Royal Melbourne Hospital and the University of Melbourne in Australia.
The finding may lead to improved... |
Novel way to disarm cancer protein identified
Washington, Nov 13 (ANI): Scientists at US Dana-Farber Cancer Institute have discovered a novel way to disarm a protein thought to play a key role in leukaemia and other cancers.
The protein in question, called Notch, is often found to be damaged or... |
Novel therapy to destroy cancer cells via laser drug activation
London, Oct 13 (ANI): A revolutionary cancer treatment, called the Photodynamic therapy (PDT), could destroy cells in a patient's tumour without any side effects of surgery or chemotherapy.
PDT uses a laser to activate an otherwise harmless drug inside... |
